Content area

|
|

Terapeutisk cancervaccination mod hæmatologisk cancer

Forfatter(e)
Morten Orebo Holmström1, Jacob Handlos Grauslund1, Nicolai Grønne Dahlager-Jørgensen1, Uffe Klausen1, Hans Carl Hasselbalch2 & Mads Hald Andersen1, 3
1) Nationalt Center for Cancer Immunterapi, Herlev Hospital 2) Hæmatologisk Afdeling, Sjællands Universitetshospital, Roskilde 3) Institut for Immunologi og Mikrobiologi, Det Sundhedsvidenskabelige Fakultet, Københavns Universitet

Ugeskr Læger 2019;181: V04190233
Reference: 
Ugeskr Læger 2019;181:V04190233
Blad nummer: 

Morten Orebo Holmström, Jacob Handlos Grauslund, Nicolai Grønne Dahlager-Jørgensen, Uffe Klausen, Hans Carl Hasselbalch & Mads Hald Andersen:

Therapeutic cancer vaccination for treatment of haematological cancers

Ugeskr Læger 2019;181:V04190233

Few trials testing the clinical efficacy of therapeutic cancer vaccination have been successful, and therapeutic cancer vaccines are yet to enter the clinic for treatment of haematological cancers. The review summarises the present knowledge of the interplay between cancer and the immune system. These novel insights have uncovered knowledge, which can be used to enhance the effect of therapeutic cancer vaccines in haematology. Immune checkpoint inhibitors, immunomodulating agents, radiotherapy and vaccination against regulatory mechanisms can potentially increase the clinical effect of cancer vaccines for haematological cancer.

Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Marianne Puge Nielsen | 13/11
1 Kommentar
af Akil Raad Kami Abdel-Wahab Walli | 13/11
6 kommentarer
af Larry Højgaard Kristiansen | 11/11
1 Kommentar
af Sven Refslund Poulsen | 09/11
3 kommentarer
af Christian Crüger | 06/11
1 Kommentar
af Anders Christiansen | 05/11
1 Kommentar
af Thamilini Umaramanan | 05/11
2 kommentarer